Literature DB >> 19764103

Delayed presentation of intrathoracic esophageal perforation after pneumatic dilation for achalasia.

Ming-Tzung Lin1, Wei-Chen Tai, King-Wah Chiu, Yeh-Pin Chou, Ming-Chao Tsai, Tsung-Hui Hu, Chuan-Mo Lee, Chi-Sin Changchien, Seng-Kee Chuah.   

Abstract

Pneumatic dilation (PD) is considered to be a safe and effective first line therapy for achalasia. The major adverse event caused by PD is esophageal perforation but an immediate gastrografin test may not always detect a perforation. It has been reported that delayed management of perforation for more than 24 h is associated with high mortality. Surgery is the treatment of choice within 24 h, but the management of delayed perforation remains controversial. Hereby, we report a delayed presentation of intrathoracic esophageal perforation following PD in a 48-year-old woman who suffered from achalasia. She completely recovered after intensive medical care. A review of the literature is also discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19764103      PMCID: PMC2747072          DOI: 10.3748/wjg.15.4461

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  Review article: the management of achalasia - a comparison of different treatment modalities.

Authors:  J M Lake; R K H Wong
Journal:  Aliment Pharmacol Ther       Date:  2006-09-15       Impact factor: 8.171

2.  Diagnosis and management of esophageal perforations.

Authors:  R K White; D M Morris
Journal:  Am Surg       Date:  1992-02       Impact factor: 0.688

3.  Delayed presentation of thoracic esophageal perforation after blunt trauma.

Authors:  Aaron W Bernard; Kfir Ben-David; Timothy Pritts
Journal:  J Emerg Med       Date:  2007-08-29       Impact factor: 1.484

4.  A management algorithm for esophageal perforation.

Authors:  Jon Kiev; Michael Amendola; Doumit Bouhaidar; Bimaljit S Sandhu; Xian Zhao; James Maher
Journal:  Am J Surg       Date:  2007-07       Impact factor: 2.565

5.  The role of esophagectomy in the management of esophageal perforations.

Authors:  A Altorjay; J Kiss; A Vörös; E Szirányi
Journal:  Ann Thorac Surg       Date:  1998-05       Impact factor: 4.330

6.  Esophageal perforation. Analysis of 10 cases.

Authors:  R Quintana; T D Bartley; M W Wheat
Journal:  Ann Thorac Surg       Date:  1970-07       Impact factor: 4.330

Review 7.  Etiology and pathogenesis of achalasia: the current understanding.

Authors:  Woosuk Park; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

8.  Esophageal perforation: comparison of use of aqueous and barium-containing contrast media.

Authors:  A Buecker; B B Wein; J M Neuerburg; R W Guenther
Journal:  Radiology       Date:  1997-03       Impact factor: 11.105

Review 9.  Current results of therapy for esophageal perforation.

Authors:  L B Reeder; V J DeFilippi; M K Ferguson
Journal:  Am J Surg       Date:  1995-06       Impact factor: 2.565

10.  Management of delayed intrathoracic esophageal perforation with modified intraluminal esophageal stent.

Authors:  J-H Zhou; T-Q Gong; Y-G Jiang; R-W Wang; Y-P Zhao; Q-Y Tan; Z Ma; Y-D Lin; B Deng
Journal:  Dis Esophagus       Date:  2009-01-23       Impact factor: 3.429

View more
  3 in total

Review 1.  Current status in the treatment options for esophageal achalasia.

Authors:  Seng-Kee Chuah; Chien-Hua Chiu; Wei-Chen Tai; Jyong-Hong Lee; Hung-I Lu; Chi-Sin Changchien; Ping-Huei Tseng; Keng-Liang Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  2011 update on esophageal achalasia.

Authors:  Seng-Kee Chuah; Pin-I Hsu; Keng-Liang Wu; Deng-Chyang Wu; Wei-Chen Tai; Chi-Sin Changchien
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

Review 3.  Endoscope-guided pneumatic dilation for treatment of esophageal achalasia.

Authors:  Seng-Kee Chuah; Keng-Liang Wu; Tsung-Hui Hu; Wei-Chen Tai; Chi-Sin Changchien
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.